Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
Yifei Tan, Xiaoyun Zhang, Wei Zhang, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 12, pp. 2038-2046
Closed Access | Times Cited: 25

Showing 25 citing articles:

Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China
Yebei Liang, Hongli Chen, Yuexing Liu, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. 88-97
Open Access | Times Cited: 139
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang‐Wook Yi
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 773-789
Open Access | Times Cited: 49
MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 947-964
Open Access | Times Cited: 27
Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 777-777
Open Access | Times Cited: 8
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
Cori Campbell, Tingyan Wang, Anna McNaughton, et al.
Journal of Viral Hepatitis (2020) Vol. 28, Iss. 3, pp. 493-507
Open Access | Times Cited: 68
Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B
Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2266-2277
Closed Access | Times Cited: 57
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
Satinder Kaur, Arslan Talat, Hamidreza Karimi‐Sari, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 25
Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study
Tomàs López‐Jiménez, Talita Duarte‐Salles, Oleguer Plana‐Ripoll, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264634-e0264634
Open Access | Times Cited: 25
Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients
Yifei Tan, Ting Duan, Bo Li, et al.
Quantitative Imaging in Medicine and Surgery (2021) Vol. 12, Iss. 1, pp. 215-228
Open Access | Times Cited: 28
Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
Fan Yang, Beibei Ni, Qinghai Lian, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 9
Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis
Lun‐Jie Yan, Long-Shan Yang, Yu‐Chuan Yan, et al.
European Journal of Cancer (2023) Vol. 185, pp. 150-163
Closed Access | Times Cited: 9
Autoimmune hepatitis and metabolic syndrome‐associated disease development: a U.S. cohort study
Muhammad I. Jalal, Mihir Brahmbhatt, Kelsey Green, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 7, pp. 1183-1193
Closed Access | Times Cited: 10
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma
Tracey G. Simon, Andrew T. Chan
Clinics in Liver Disease (2020) Vol. 24, Iss. 4, pp. 549-576
Open Access | Times Cited: 13
Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
Su-Hua Yang, Yi-Shan He, Shuqin Zheng, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 737-746
Open Access | Times Cited: 1
Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia
Tomàs López‐Jiménez, Oleguer Plana‐Ripoll, Talita Duarte‐Salles, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Increased Risk of Liver-Related Outcomes in Chronic Hepatitis B Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis
Khin Naing Thin, Andrew Tran, Jie Li, et al.
Digestive Diseases (2022) Vol. 40, Iss. 6, pp. 745-753
Open Access | Times Cited: 6
High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
Jan‐Hendrik Bockmann, Matin Kohsar, John M. Murray, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 968-968
Open Access | Times Cited: 7
The Effect of Metabolic Syndrome on the Outcome of Hepatitis B-Associated Hepatocellular Carcinoma Patients After Hepatectomy: A Multicenter Study
Junlong Dai, Xinrui Zhu, Junyi Shen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection
Ana Caroline Ferreira da Silva, Marlone Cunha‐Silva, Tiago Sevá‐Pereira, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1968-1968
Open Access | Times Cited: 4
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
Cori Campbell, Tingyan Wang, Anna McNaughton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
Kyoko Oura, Asahiro Morishita, Joji Tani, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1279-1298
Open Access | Times Cited: 3
The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinoma
Thuy‐Van P. Hang, Joel Wedd
Chinese Clinical Oncology (2020) Vol. 10, Iss. 1, pp. 4-4
Open Access | Times Cited: 3
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis
Qian Zhang, Kexiang Zhou, Wei Liang, et al.
Journal of International Medical Research (2020) Vol. 48, Iss. 10
Open Access | Times Cited: 3
Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
(2023)
Open Access | Times Cited: 1
Investigation on hepatitis B surface antigen among exit personnel at Tianjin port of China in 2019
Shao Cuicui, Xiaojun Chen, Chunqi Wang, et al.
Medical Research and Innovations (2020) Vol. 4, Iss. 3
Open Access
Page 1

Scroll to top